NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure in the Inpatient Setting

CompletedNA

Sponsor: Yale University

Conditions: Heart Failure

Interventions: Best practice alert for the notification of patient HFrEF and recommended evidence-based medical therapies (NO drugs are being administered in this trial)

Countries: United States

A randomized single-blind interventional trial to test the effectiveness of an electronic medical record-based best practice alert recommending evidence-based medical therapies versus usual care in inpatient adult patients presenting with heart failure with reduced ejection fraction.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Adults ≥18 years admitted to a hospital within the Yale New Haven Hospital system (either Yale New Haven Hospital, St. Raphael's Campus, Greenwich Hospital, or Bridgeport Hospital).
* Have HFrEF defined as:

  1. NT-pro-BNP \>500 pg/ml within 24 hours of admission
  2. On IV loop diuretic within 24 hours of admission
  3. Left ventricular ejection fraction ≤40% (most recent)

Exclusion Criteria:

* Patients within 48 hours of admission
* Patients in the intensive care unit
* Patients on hospice service
* Patients receiving intravenous milrinone
* Patient on NPO (nothing by mouth) order
* Patients on all evidence based medical therapy for HFrEF (on all 4 classes of evidence based medical therapy: beta-blockers, ACEi/ARB/ARNI, MRA, SGLT2i)
* Opted out of medical record research

Locations (1)

New Haven, Connecticut, United States